132 related articles for article (PubMed ID: 37590274)
1. A picogram BA-ELISA quantification assay for rLj-RGD3, a platelet fibrinogen receptor antagonist, in the rat plasma and its application to a pharmacokinetic study.
Wang Y; Liu Z; Han G; Yu P; Yang X; Wang J; Lv L
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011568. PubMed ID: 37590274
[TBL] [Abstract][Full Text] [Related]
2. rLj-RGD3, a Novel Recombinant Toxin Protein from Lampetra japonica, Protects against Cerebral Reperfusion Injury Following Middle Cerebral Artery Occlusion Involving the Integrin-PI3K/Akt Pathway in Rats.
Lu Q; Wang J; Jiang J; Wang S; Jia Q; Wang Y; Li W; Zhou Q; Lv L; Li Q
PLoS One; 2016; 11(10):e0165093. PubMed ID: 27768719
[TBL] [Abstract][Full Text] [Related]
3. rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.
Wang S; Jiang J; Wang Y; Jia Q; Dai S; Wang Y; Lv L; Wang J
Biochem Biophys Res Commun; 2018 Mar; 498(1):240-245. PubMed ID: 29407168
[TBL] [Abstract][Full Text] [Related]
4. [Anti-angiogenic activities of Lj-RGD3 toxin protein from Lampetra japonica and its mutation protein Lj-112 without RGD motifs].
Wang J; Zhang Y; Lü L; Liu X; Li Q
Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1428-37. PubMed ID: 22260059
[TBL] [Abstract][Full Text] [Related]
5. rLj-RGD3, a Novel Three-RGD-Motif-Containing Recombinant Protein from
Lv L; Lu Q; Shao F; Li W; Zhou Q; Wang J; Li Q
Biomed Res Int; 2016; 2016():6701249. PubMed ID: 27689087
[TBL] [Abstract][Full Text] [Related]
6. [Expression and bioactivity effects to Hela of recombinant toxin protein rLj-RGD3 from Lampetra japonica].
Zhang P; Wang J; Liu X; Chu D; Li Q
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):686-94. PubMed ID: 19670636
[TBL] [Abstract][Full Text] [Related]
7. A novel RGD-toxin protein, Lj-RGD3, from the buccal gland secretion of Lampetra japonica impacts diverse biological activities.
Wang J; Han X; Yang H; Lu L; Wu Y; Liu X; Guo R; Zhang Y; Zhang Y; Li Q
Biochimie; 2010 Oct; 92(10):1387-96. PubMed ID: 20650303
[TBL] [Abstract][Full Text] [Related]
8. The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells.
Jin Y; Lv L; Ning SX; Wang JH; Xiao R
Anticancer Agents Med Chem; 2019; 19(17):2108-2119. PubMed ID: 31642792
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effects of the recombinant toxin protein rLj-RGD3 from Lampetra japonica on pancreatic carcinoma Panc-1 cells in nude mice.
Wang Y; Zheng Y; Tu Z; Dai Y; Xu H; Lv L; Wang J
Peptides; 2017 Feb; 88():8-17. PubMed ID: 27988354
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mutant of rLj-RGD3 (rLj-112) Suppressed the Proliferation and Metastasis of B16 Cells through the EGFR Signaling Pathway.
Zheng YY; Xiao R; Zhang LX; Yan HJ; Wang JH; Lv L
Mar Drugs; 2019 Jan; 17(2):. PubMed ID: 30821275
[TBL] [Abstract][Full Text] [Related]
11. rLj-RGD3 induces apoptosis via the mitochondrial-dependent pathway and inhibits adhesion, migration and invasion of human HeyA8 cells via FAK pathway.
Jiang Q; Li Q; Han J; Gou M; Zheng Y; Li B; Xiao R; Wang J
Int J Biol Macromol; 2017 Mar; 96():652-668. PubMed ID: 28038913
[TBL] [Abstract][Full Text] [Related]
12. Effects of the recombinant toxin protein rLj-RGD3 in multidrug-resistant human breast carcinoma cells.
Jin M; Wang J; Xiao R; Liu X; Wu F; Pang Y; Feng B; Yang D; Li Q
Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):455-61. PubMed ID: 22349023
[TBL] [Abstract][Full Text] [Related]
13. Novel anticandidal activity of a recombinant Lampetra japonica RGD3 protein.
Wu C; Lu L; Zheng Y; Liu X; Xiao R; Wang J; Li Q
J Microbiol Biotechnol; 2014 Jul; 24(7):905-13. PubMed ID: 24690634
[TBL] [Abstract][Full Text] [Related]
14. Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion.
Jin M; Xiao R; Wang J; Liu X; Liu Y; Xue Z; Lv L; Zheng Y; Li Q
Acta Biochim Biophys Sin (Shanghai); 2013 May; 45(5):377-82. PubMed ID: 23435195
[TBL] [Abstract][Full Text] [Related]
15. Data for the effects of rLj-RGD3 on normal tissues of rats and its location in HeyA8 cells.
Zheng Y; Han J; Wang Y; Jiang Q; Wang Y; Lv L; Xiao R; Wang J
Data Brief; 2017 Jun; 12():77-80. PubMed ID: 28393089
[TBL] [Abstract][Full Text] [Related]
16. rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice.
Zheng Y; Lv L; Yi L; Wu R; Xiao R; Wang J
Molecules; 2017 Dec; 22(12):. PubMed ID: 29244724
[TBL] [Abstract][Full Text] [Related]
17. rLj-RGD4, the shortened peptide of rLj-RGD3 from Lampetra japonica, protects against cerebral ischemia/reperfusion injury via the PI3K/Akt pathway.
Jia Q; Zhang X; Zhang A; Wu R; Liu Z; Chen Y; Wang J; Lv L
Peptides; 2020 Jul; 129():170310. PubMed ID: 32389578
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
Shao F; Lv M; Zheng Y; Jiang J; Wang Y; Lv L; Wang J
Biochimie; 2015 Dec; 119():183-91. PubMed ID: 26549486
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput biotin-avidin-ELISA for studying expression of platelet membrane glycoproteins and its clinical application.
Zhang Y; Zhao Y; Lu S; Zhu M; He Y; Ruan C
Tohoku J Exp Med; 2010 Sep; 222(1):83-8. PubMed ID: 20823666
[TBL] [Abstract][Full Text] [Related]
20. Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA).
Kendall C; Ionescu-Matiu I; Dreesman GR
J Immunol Methods; 1983 Feb; 56(3):329-39. PubMed ID: 6833765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
